Evereden has raised $32.0M in total across 1 funding round.
Evereden's investors include Arbor Ventures, GSR Ventures.
Evereden is a premium, clean skincare brand offering non-toxic, dermatologist-formulated products for multi-generational use, targeting babies, kids, moms, and families with sensitive skin. It provides 38 SKUs across categories like baby care, kids' lines, SPF, haircare, suncare, and eczema treatments, solving the problem of safe, efficacious skincare for delicate skin stages without harmful ingredients like sulfates, parabens, or phthalates[1][2][5]. The company serves parents and families seeking high-quality, science-backed alternatives to conventional products, with strong growth including 350% year-over-year expansion pre-2021 and a $32M Series C funding round in 2021 led by GSR Ventures[1][2].
Headquartered in New York and founded around 2018-2019, Evereden has scaled through direct-to-consumer sales, global shipping to over 200 countries, and retail expansion plans like Sephora launches, bolstered by in-house R&D for rapid innovation—such as its Kids Line, which quickly captured 20% of revenue[1][2][3][5].
Evereden emerged in 2018-2019 from a mission to reimagine family skincare, founded by Co-Founder and CEO Kimberley Ho alongside dermatologists from Stanford and Harvard who developed its safe, nourishing formulas for life's delicate stages[1][2][3][5]. The idea addressed gaps in clean, multi-generational products, starting with essentials like diaper creams and stretch mark lotions for women and kids, evolving into a full range amid rising demand for non-toxic options[3]. Early traction came from explosive growth, culminating in a pivotal $32M Series C in December 2021, enabling R&D expansion and category-first innovations like the Kids Line launched six months prior, which rapidly drove 20% of revenue by serving underserved markets[1].
While primarily a consumer skincare company, Evereden leverages tech-enabled direct-to-consumer models, e-commerce platforms (using tools like WordPress and Visual Website Optimizer), and data-driven R&D to disrupt the $2,255-company beauty & personal care sector[2][4]. It rides the clean beauty trend toward non-toxic, science-backed products amid rising parental awareness of ingredient safety, with timing amplified by post-pandemic family wellness focus and global e-commerce growth[1][5]. Market forces like tariff challenges favor its international playbook—consistent pricing across borders and exclusive online products—positioning it to influence family skincare by pioneering underserved kids/teens segments and normalizing dermatologist-grade clean routines ecosystem-wide[1][2].
Evereden's momentum positions it for continued dominance in clean family skincare, potentially deepening Sephora/global retail penetration and launching more category-first lines via enhanced R&D. Trends like AI-optimized formulations, subscription self-care for kids, and tariff-resilient DTC will shape its path, evolving its influence from niche innovator to mainstream staple in a maturing multi-generational beauty market. As the fastest-growing premium player, it redefines safe skin health for families, tying back to its core: trusted, tested, true self-care[1][2][5].
Evereden has raised $32.0M across 1 funding round. Most recently, it raised $32.0M Series C in December 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2021 | $32.0M Series C | Arbor Ventures, GSR Ventures |
